Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

346 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessment of amino-terminal C-type natriuretic peptide serum level and its correlation with high-density lipoprotein structure and function in patients with end stage renal disease before and after kidney transplantation.
Szentimrei R, Lőrincz H, Szentpéteri A, Varga VE, Seres I, Varga É, Nemes B, Harangi M, Paragh G. Szentimrei R, et al. Among authors: paragh g. Chem Biol Interact. 2023 Nov 1;385:110749. doi: 10.1016/j.cbi.2023.110749. Epub 2023 Oct 5. Chem Biol Interact. 2023. PMID: 37802408 Free article.
Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP).
Rizzo M, Colletti A, Penson PE, Katsiki N, Mikhailidis DP, Toth PP, Gouni-Berthold I, Mancini J, Marais D, Moriarty P, Ruscica M, Sahebkar A, Vinereanu D, Cicero AFG, Banach M; International Lipid Expert Panel (ILEP). Rizzo M, et al. Pharmacol Res. 2023 Mar;189:106679. doi: 10.1016/j.phrs.2023.106679. Epub 2023 Feb 8. Pharmacol Res. 2023. PMID: 36764041 Free article. Review.
Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto's thyroiditis on levothyroxine substitution.
Csiha S, Molnár I, Halmi S, Hutkai D, Lőrincz H, Somodi S, Katkó M, Harangi M, Paragh G, Nagy EV, Berta E, Bodor M. Csiha S, et al. Among authors: paragh g. Front Endocrinol (Lausanne). 2023 May 26;14:1187725. doi: 10.3389/fendo.2023.1187725. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37305044 Free PMC article.
Regional differences in physicians' behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE study.
Banach M, Lewek J, Pol K, Rabczenko D, Balanescu SM, Blaha V, Ceska R, Jankowski P, Surma S, Kolovou G, Liberopoulos E, Mitu F, Mitu M, Naji FH, Paragh G, Popławska M, Vrablik M, Pella D. Banach M, et al. Among authors: paragh g. Front Cardiovasc Med. 2023 Jun 19;10:1206551. doi: 10.3389/fcvm.2023.1206551. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37404744 Free PMC article.
346 results